Evidence map›Paper›PMID 25576625›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2015

Efficacy of prophylactic flavan-3-ol in permanent focal ischemia in 12-mo-old mice.

Christopher C Leonardo, Monique Mendes, Abdullah S Ahmad, Sylvain Doré

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christopher C LeonardoDepartment of Anesthesiology and Center for Translational Research and Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, Florida; and.
Monique MendesDepartment of Anesthesiology and Center for Translational Research and Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, Florida; and.
Abdullah S AhmadDepartment of Anesthesiology and Center for Translational Research and Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, Florida; and.
Sylvain DoréDepartment of Anesthesiology and Center for Translational Research and Neurodegenerative Disease, College of Medicine, University of Florida, Gainesville, Florida; and Departments of Neurology, Psychiatry and Neuroscience, College of Medicine, University of Florida, Gainesville, Florida sdore@ufl.edu.
University of Florida · US

Funding

Effect of Flavanol-Rich Cocoa Extract in Acute Neurodegenerative ConditionsR21AT005085 · NCCIH · UNIVERSITY OF FLORIDA · PI DORE, SYLVAIN · 2010 to 2011
$423k
Stilbene's Contribution in Hemorrhagic StrokeR21AT005246 · NCCIH · UNIVERSITY OF FLORIDA · PI DORE, SYLVAIN · 2010 to 2011
$423k
NCCIH NIH HHS R21 AT005085NCCIH NIH HHS R21AT005085NCCIH NIH HHS R21 AT005246NCCIH NIH HHS R21AT005246
6 · The paper itself

Abstract

The consumption of flavan-3-ol-containing foods, including (-)-epicatechin (EC), has been linked to lower incidence of cardiovascular disease and stroke. We previously demonstrated nuclear transcription factor erythroid 2p45-related factor-2 (Nrf2) -dependent EC efficacy in reducing stroke-induced deficits in 2-mo-old mice; yet stroke is primarily a disease of the elderly. Because neuroinflammation, oxidative stress, and vascular dysfunction are hallmarks of aging, we tested whether Nrf2 mediates EC efficacy in aging mice through modulation of glial responses and blood brain barrier permeability. First, we compared anastomosis in naïve wild-type and C57BL/6 Nrf2(-/-) mice to identify potential differences in cerebrovascular architecture. Data showed no significant differences in the number of anastomoses or mean intersection points, indicating similar gross vascular physiology. To assess efficacy and mechanisms of protection, wild-type or Nrf2(-/-) mice were administered the minimum effective EC dose established in our previous studies before the permanent distal middle cerebral artery occlusion. Similar to previous results with young mice, 12-mo-old wild types also showed significant reductions in infarct volume (41.01 ± 29.57%) and improved performance in removing adhesive tape relative to vehicle-treated controls, whereas a trend toward protection was observed in Nrf2(-/-). However, EC did not reduce immunoreactivity for the microglia/macrophage marker anti-ionized calcium-binding adapter molecule 1, suggesting that dampened activation/recruitment did not account for EC protection. Furthermore, there were no differences in mouse IgG extravasation or spontaneous hemorrhage between EC-treated groups. These data demonstrate that EC protection occurs independent of microglia/macrophage modulation or blood brain barrier preservation, suggesting that the glial cell responses in young mice are compensatory to another, and potentially novel, protective mechanism.

Indexed as

Age FactorsAnimalsBlood-Brain BarrierBrainCapillary PermeabilityDisease Models, AnimalFlavonoidsGaitInfarction, Middle Cerebral ArteryMacrophagesMaleMice, Inbred C57BLMice, KnockoutMicrogliaNeurogliaNeuroprotective Agentsflavan-3-olFlavonoidsNeuroprotective AgentsNfe2l2 protein, mouseNF-E2-Related Factor 2behaviorcentral nervous systemcerebrovascularinflammationstroke

Identifiers

PMID25576625
PMCPMC4360057
OpenAlexW1988301880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.